Metraipolis › archive › dc_dd2fb8c24bcc

Myositis-Myasthenia Overlap Syndrome After Immune Checkpoint Inhibitor Treatment: A Case Report — Europe PMC PMID:42181373

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42181373
DOI
10.7759/cureus.107600
License (as archived)
solo-consultazione
Archived
2026-11-03T07:56:23.198Z
SHA-256 of the archived text
4c66604983df613c0737fa5f8bed81ef443b4ba06c8ea3d2488cbfdc4d8f171b
Stable URL of this page
https://metraipolis.com/documento/dc_dd2fb8c24bcc

How to cite

Myositis-Myasthenia Overlap Syndrome After Immune Checkpoint Inhibitor Treatment: A Case Report — Europe PMC PMID:42181373 — Europe PMC (en), https://europepmc.org/article/MED/42181373 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dd2fb8c24bcc (Metraipolis archive dc_dd2fb8c24bcc, sha256 4c66604983df613c0737fa5f8bed81ef443b4ba06c8ea3d2488cbfdc4d8f171b)
BibTeX
@misc{dcdd2fb8c24bcc,
  title = {Myositis-Myasthenia Overlap Syndrome After Immune Checkpoint Inhibitor Treatment: A Case Report — Europe PMC PMID:42181373},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42181373},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dd2fb8c24bcc; sha256 4c66604983df613c0737fa5f8bed81ef443b4ba06c8ea3d2488cbfdc4d8f171b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42181373. Agents can read the archived copy with the MCP tool read_document.